Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
37,253,000
-
Total 13F shares
-
23,496,502
-
Share change
-
-447,347
-
Total reported value
-
$272,006,071
-
Put/Call ratio
-
0%
-
Price per share
-
$11.58
-
Number of holders
-
94
-
Value change
-
-$4,453,715
-
Number of buys
-
43
-
Number of sells
-
44
Institutional Holders of LIFECORE BIOMEDICAL, INC. \DE\ - Common Stock (LFCR) as of Q1 2022
As of 31 Mar 2022,
LIFECORE BIOMEDICAL, INC. \DE\ - Common Stock (LFCR) was held by
94 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,496,502 shares.
The largest 10 holders included
WYNNEFIELD CAPITAL INC, Legion Partners Asset Management, LLC, DIMENSIONAL FUND ADVISORS LP, BlackRock Inc., Cove Street Capital, LLC, VANGUARD GROUP INC, 22NW, LP, HEARTLAND ADVISORS INC, MORGAN STANLEY, and Pacific Ridge Capital Partners, LLC.
This page lists
94
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.